Six Years for Ruti Aga: A Forged Prescription Closed the One Door That Could Have Saved Her

The first roar in Bhubaneswar always arrives late. I heard it in 2026 — between half-empty seats, when Neeraj Chopra threw 85.23m and the microphone swung toward me. Athletics' real examination did not begin inside the stadium that day but outside it: which railway division would hand over a job, which coach would absorb the cost, and which registered doctor an injured athlete would be sent to. Reading the news of Ruti Aga's six-year ban, the same question came back — except this time there was no answer, only a forged prescription. Every host knows the moment before the lights, when the arena is still a rumour; here the arena had already emptied.

Ethiopia's 32-year-old marathon runner Ruti Aga has been banned for six years by the Athletics Integrity Unit (AIU). A sample taken after she won a half marathon in China in March tested positive for methylprednisolone. Aga cited a knee injury and submitted treatment documents. The investigation found the document forged: the 'doctor' who wrote the prescription was a family member with no medical registration, who claimed he had used an old prescription pad left behind by a former workplace. That clinic did not exist. The sanction split in two: two years for the presence violation, four years for tampering — the fabricated document and misleading statements during interview. The ban runs from 10 September, which is also the date of her provisional suspension. No mark, split or field strength from that March race is recorded anywhere — so do not infer form from the fact that she won.

Here is the first thing being technically misreported: the class of the substance. Methylprednisolone is being called a 'prohibited steroid', when it is a glucocorticoid — WADA Prohibited List class S9, not an anabolic steroid (S1). The difference is not semantic. S9 glucocorticoids are prohibited in-competition only, and only via injection, oral or rectal routes. A therapeutic knee injection given out-of-competition is entirely legal. The issue is route and timing relative to the competition, not whether the substance is a 'doping' agent.

That is why Aga's entire defence rested on one thing: records. Had she possessed a genuine medical file — when the injection was given, by which registered physician, by which route — the case could have landed in no-fault or no-significant-fault territory, with no tampering charge at all. The forged prescription destroyed the one defence that might have worked. That is the bitterest irony of the case: fabricating the document itself became evidence of intent to conceal.

Two plus four is standard. Under the Code, two years is normal for a Specified Substance finding, and four years is the standard tampering sanction. The arithmetic tells us the panel accepted an absence of proven intent but held the documentary tampering fully culpable. Backdating to 10 September is no relief — provisional suspension time counts against the ban, leaving the athlete with almost nothing in real terms.

Now the part that rarely makes the news. China's label half-marathon circuit functions as an 'appearance-fee' economy for East African marathoners — a lucrative, low-risk tier between the Majors and smaller races. That same tier has now become the AIU's highest-yield testing ground. Two economies — of fees and of testing — are colliding in the same race, and the athlete is the weakest link in that collision.

My own experience demands honesty here. After Bhubaneswar I built 'The Track Diaries', profiling emerging athletes' inner journeys. Back then I believed the story was enough. This case shows the story breaks where an athlete with a knee injury, no team physician, is trapped inside a system where a registered doctor is simply hard to find. In that empty-pitch session in Russia I learned it — snow learns to fall, slowly, then all at once. Aga's collapse was the same: years of informal treatment, and then one prescription pad that flattened everything.

This sanction will be cited as proof of AIU rigour. I read it differently. A six-year ban for a substance with no proven endurance benefit in distance running signals that the enforcement frontier has shifted from 'detection' to 'document verification'. That rigour is welcome, but it carries a blind spot: the athlete without formal medical support is the one who falls into the forgery trap. And the family-member 'doctor' aggravates rather than mitigates. Three separate verifications failed — no clinic, no registration, and the clinic explicitly disowning the pad. But the real question is whether any agent, manager or coach was investigated. Only one family member is named. The athlete is serving this alone, and that solitude is itself a failure.

Six years at 32 means returning at roughly 38 — in the depth of Ethiopian women's marathon running, that age and that record sit outside selection range. Her 2026 Tokyo Marathon title and three Major runner-up finishes remain her permanent record; they predate the ban, and the case contains no finding of earlier use. The next question is not when Aga returns. It is which registered doctor the next Ethiopian runner with a knee injury — one who has nobody to manufacture a pad — will be sent to. No anti-doping report answers that.